Skip to main content
Lippincott Open Access logoLink to Lippincott Open Access
. 2023 Jul 13;51(8):e177. doi: 10.1097/CCM.0000000000005960

Prognostic and Predictive Biomarkers in Patients With Coronavirus Disease 2019 Treated With Tocilizumab in a Randomized Controlled Trial: Erratum

PMCID: PMC12442771  PMID: 37439653

In the article beginning on page 398 of the March 2022 issue, there was an incorrect unit in Table 1.

In the first column for Biomarkers, Interleukin-6 unit should have been ng/L.

REFERENCE

  1. Tom J, Bao M, Tsai L, et al. : Prognostic and predictive biomarkers in patients with coronavirus disease 2019 treated with tocilizumab in a randomized controlled trial. Crit Care Med. 2022; 50:398–409 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Critical Care Medicine are provided here courtesy of Wolters Kluwer Health

RESOURCES